Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: Relation to metabolic imaging by PET

Journal of Nuclear Cardiology

Volumn 10, Issue 6, 2003, Pages 599-606

  He, Wei ^a   Acampa, Wanda ^a   Mainolfi, Ciro ^a   Menna, Francesco ^a   Sorrentino, Anna Rita ^a,b   Petretta, Mario ^a   Cuocolo, Alberto ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Cardiac metabolism; Left ventricular dysfunction; Nitrate; Tetrofosmin

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NITRATE; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG UPTAKE; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0346829892     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(03)00649-4     Document Type: Article

References (36)

1. Patterson RE, Pilcher WC. Assessing myocardial viability to help select patients for revascularization to improve left ventricular dysfunction due to coronary artery disease. Semin Thorac Cardiovasc Surg 1995;7:214-26.
2. Ragosta M, Beller GA. The noninvasive assessment of myocardial viability. Clin Cardiol 1993;16:531-8.
3. Marwick TH, Zuchowski C, Lauer MS, et al. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 1999;33:750-8.
4. Paeng JC, Lee DS, Cheon GJ, et al. Consideration of perfusion reserve in viability assessment by myocardial Tl-201 rest-redistribution SPECT: a quantitative study with dual-isotope SPECT. J Nucl Cardiol 2002;9:68-74.
5. Saha GB, MacIntyre WJ, Brunken RC, et al. Present assessment of myocardial viability by nuclear imaging. Semin Nucl Med 1996; 26:315-35.
6. 18F-fluorodeoxyglucose. Circulation 1991;83:26-37.
7. Bax J, Wijins W. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging? J Nucl Med 1999;40:1893-5.
8. Yoshinaga K, Morita K, Yamada S, et al. Low-dose dobutamine electrocardiography-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET. J Nucl Med 2001;42:838-44.
9. Acampa W, Cuocolo A, Petretta M, et al. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy. J Nucl Cardiol 2002;9:33-40.
10. Matsunari I, Fujino S, Taki J, et al. Myocardial viability assessment with technetium-99m tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995;36: 1961-7.
11. 99mTc-sestamibi. Circulation 1994;89:2552-61.
12. Sciagrà R, Leoncini M, Marcucci G, Dabizzi RP, Pupi A. Technetium-99m sestamibi imaging to predict left ventricular ejection fraction outcome after revascularization in patients with chronic coronary artery disease and left ventricular dysfunction: comparison between baseline and nitrate enhanced imaging. Eur J Nucl Med 2001;28:680-7.
13. 201Tl imaging. Nucl Med Commun 1996;17:864-71.
14. Cuocolo A, Acampa W, Nicolai E, et al. Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction. J Nucl Cardiol 2000;7:8-15.
15. Leoncini M, Marcucci G, Sciagrà R, et al. Usefulness of distinct activity thresholds according to baseline regional asynergy for predicting functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction: a study with nitrate-enhanced sestamibi gated SPECT. J Nucl Cardiol 2001;8: 555-60.
16. Cuocolo A, Petretta M, Nicolai E, et al. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med 1998;25:60-8.
17. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
18. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley and Sons; 1981. p. 217-25.
19. Baer FM, Erdmann E. Methods of assessment and clinical relevance of myocardial hibernation and stunning. Assessment of myocardial viability. Thorac Cardiovasc Surg 1998;46(Suppl 2): 264-9.
20. He ZW, Verani MS, Liu XJ. Nitrate-augmented myocardial imaging for assessment of myocardial viability. J Nucl Cardiol 1995; 2:352-7.
21. Miyanaga H, Kunieda Y, Oguni A, et al. Improved detection of fill-in using sublingual nitroglycerin in technetium-99m tetrofosmin exercise/rest single protocol for old myocardial infarction. J Cardiol 1999;33:135-43.
22. Oudiz RJ, Smith DE, Pollak AJ, et al. Nitrate-enhanced thallium 201 single-photon emission computed tomography imaging in hibernating myocardium. Am Heart J 1999;138:369-75.
23. Wadhwa SS, Mansberg R, Fernandes VB. Tl-201 myocardial perfusion SPECT: role of nitrate-augmented redistribution. Clin Nucl Med 1999;24:1-5.
24. Flotats A, Carrio I, Estorch M, et al. Nitrates administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography. Eur J Nucl Med 1997;24:767-73.
25. Thorley PJ, Sheard KL, Wright DJ, Sivananthan UM. The routine use of sublingual GTN with resting 99m-Tc-tetrofosmin myocardial perfusion imaging. Nucl Med Commun 1998;19:937-42.
26. Abrams J. Hemodynamic effects of nitroglycerin and long-acting nitrates. Am Heart J 1985;110:216-24.
27. Brown BG, Bolson E, Peterson RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilation as a major component of the drug response. Circulation 1981;64:1089-97.
28. Aoki M, Sakai K, Koyanagi S, Takeshita A, Nakamura M. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography. Am Heart J 1991;121:1361-6.
29. He ZX, Medrano R, Hays JT, Mahmarian JJ, Verani MS. Nitroglycerin-augmented Tl-201 reinjection enhances detection of reversible myocardial hypoperfusion. A randomized, double-blind, parallel, placebo-controlled trial. Circulation 1997;95:1799-805.
30. Cohn PF, Maddox D, Holman BL, et al. Effect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am J Cardiol 1977;39:672-8.
31. Fallen EL, Nahmias C, Scheffel A, et al. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation 1995;91:1381-8.
32. Mahmarian JJ, Fenimore NL, Marks GF, et al. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography. J Am Coll Cardiol 1994;24:25-32.
33. He ZX, Kou RW, Liu XJ. Measurements of the effects of percutaneous nitroglycerin on left ventricular performance in patients with coronary artery disease with a cardiac probe. Eur J Nucl Med 1988;14:374-7.
34. Lahiri A, Crawley JC, Sonecha TN, Raftery EB. Acute and chronic effects of sustained action buccal nitroglycerin in severe congestive heart failure. Int J Cardiol 1984;5:39-48.
35. Matsunari I, Boning G, Ziegler SI, et al. Attenuation-corrected Tc-99m tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using F-18 fluorodeoxyglucose. J Am Coll Cardiol 1998;32:927-35.
36. Mabuchi M, Kubo N, Morita K, et al. Prediction of functional recovery after coronary bypass surgery using quantitative gated myocardial perfusion SPECT. Nucl Med Commun 2003;24:625-31.